Hair loss: the 3 things that work, the 12 that don't, the protocol nobody sells you.

Your hairline isn't fading because of stress. It's fading because DHT is shrinking the follicles.

The Big 3 protocol — finasteride, minoxidil, ketoconazole — stops 80% of the loss for 80% of men. Three molecules, all decades old, all generic, all under $40 a month combined if you route them right (under $30 if you split tablets and use OTC Nizoral).

Most online clinics will sell you four products at $200 a month, with the cheapest leg of the protocol (ketoconazole) usually missing entirely. The other three get bundled with biotin, "scalp serums," and supplement gummies that do nothing.

This is the version a friend with a pharmacology textbook would write you over coffee. It's long. Hair is not a one-paragraph problem.

You will leave with: the three molecules that actually work, the twelve that mostly don't, a 24-month timeline of what to expect (including the part where your hair gets worse before it gets better), a decision tree for side effects, and a price anchor across every tier.

A note before you start

We route finasteride, dutasteride, minoxidil, and ketoconazole orders to licensed personal-import pharmacies. So we have a financial reason to want this article to lead you toward "start the protocol." Read it with that in mind. The protocol below is what we'd tell a friend, not what maximizes reorder rate.

Section 1 — Why your hair is falling out (mechanism in 90 seconds)

Androgenetic alopecia, the cause of ~95% of male pattern hair loss, is one molecule shrinking one follicle.

Testosterone is converted by the enzyme 5-alpha reductase into dihydrotestosterone (DHT). DHT binds to androgen receptors in genetically susceptible scalp follicles. The follicles miniaturize — each growth cycle produces a thinner, shorter, less pigmented hair, until eventually no terminal hair grows there at all.

It is not stress. Stress causes telogen effluvium, which is diffuse, fully reversible, and usually clears in 3-6 months. Pattern loss is anatomically specific (frontal, vertex, temples), progressive, and DHT-driven.

It is not your shampoo. It is not blood flow to the scalp. It is not insufficient biotin. It is one enzyme, one hormone, one receptor.

Once you accept that, the protocol writes itself: block the enzyme (finasteride/dutasteride), reverse the miniaturization (minoxidil), and reduce scalp DHT plus inflammatory load locally (ketoconazole).

That is the Big 3. Everything else is the optional 20%.

Section 2 — The Big 3, the 80% you can't skip

Leg 1: Finasteride 1mg/day (oral)

The 5-alpha reductase inhibitor. Suppresses serum DHT by ~70% and scalp DHT by ~64% at 1mg/day. Stops the miniaturization process at the source.

The pivotal trial: Kaufman et al. JAAD 1998 (n=1,553, finasteride 1mg vs placebo, 1-2 years). At year 1, finasteride increased hair count by 107 hairs in a 1-inch target zone; placebo lost ground. At year 2, +138 hairs. P<.001 for every endpoint. Five-year follow-up (Finasteride Male Pattern Hair Loss Study Group, 2002) showed ~90% of finasteride users retained or grew hair, while ~75% of placebo users had visible progression.

This is the most rigorously studied hair drug in human history. It works. The side-effect math is its own conversation — see our finasteride side-effects piece for the trial-vs-Reddit number split.

Standard dose: 1mg/day, oral, indefinitely. Stops working when you stop taking it. Hair lost in the 6-12 months after discontinuation is roughly equivalent to never having taken it.

Leg 2: Minoxidil — topical 5% twice daily, OR oral 2.5mg once daily

A potassium-channel opener and vasodilator originally developed for severe hypertension. The mechanism in hair is not just blood flow — it shortens the telogen (resting) phase, lengthens the anagen (growth) phase, and reverses follicle miniaturization. Effect is mostly cosmetic gain — adds new hairs and thickens existing ones. It does not block DHT.

Topical 5%: 1mL twice daily to the scalp. The original FDA-approved use. Cheap, OTC in most markets, well-studied. The downside: it's messy, sticky if it's the propylene-glycol solution, requires twice-daily compliance, and 30-40% of users report scalp irritation (most of which is the vehicle, not minoxidil).

Oral 2.5mg: the off-label workaround. Carvalho Fonseca et al. JAAD 2026 (PMID 40962189, double-blind RCT comparing 2.5mg vs 5mg oral) found 2.5mg comparably effective to 5mg with a meaningfully cleaner side-effect profile. The largest safety dataset is Vañó-Galván et al. JAAD 2021 (n=1,404, doi:10.1016/j.jaad.2021.02.054): hypertrichosis 15.1%, treatment-stopping side effects only 1.7%, no life-threatening events.

If topical mino is making your scalp itch or your pillow look like a cooking-grease museum, oral 2.5mg is the answer. See our oral minoxidil deep dive.

Leg 3: Ketoconazole 2% shampoo, 2-3 times per week

The cheapest leg of the protocol and the one telehealth clinics consistently leave out.

Pierard-Franchimont et al. Dermatology 1998 (PMID 9669136) showed long-term ketoconazole 2% shampoo use produced hair density and shaft diameter improvements comparable in magnitude to topical 2% minoxidil in a head-to-head arm. The mechanism is debated — partial topical anti-androgen activity, anti-inflammatory effect on the perifollicular Malassezia-driven inflammation, both, or neither. Empirically, it works.

Use: lather, leave on the scalp 3-5 minutes, rinse. Two to three times per week. The other days use a normal shampoo.

OTC Nizoral 1% in the US is roughly half the strength of the prescription 2% but is what most people end up using because it's $15 at any drugstore. The 2% formulation is OTC in most non-US markets and routed through us as a cream or shampoo at slightly higher cost.

This leg of the protocol costs $5-15 a month. It is the single biggest "you'd never know it existed" lever in the whole stack. The $200 hair-clinic bundles almost never include it.

Section 3 — The 24-month timeline (and the part where it gets worse)

If you start the Big 3 today, this is approximately what you'll see. Honest version, not the marketing version.

Month 0 — baseline. Take photos: front, left side, right side, top-down vertex. Identical lighting, dry hair, same time of day. Hold a $5 ruler against the hairline as scale. This is the only objective record you will have. Most men skip this and then can't tell at month 12 whether anything changed.

Weeks 4-12 — the dread shed. Your hair will look worse than at month 0. This is real, and it's a signal the drug is working. Finasteride and minoxidil both shorten the resting phase and synchronize follicles into anagen — hairs that were sitting in telogen waiting to fall out fall out all at once over 4-12 weeks, instead of gradually over the next year. Net hair count is the same. Visual density temporarily drops.

This is when 30% of men quit. They are quitting at the exact moment the drug is restructuring the follicle cycle in their favor.

Don't quit. Take a photo at month 3. Compare to month 0. Yes, it's worse. Continue.

Months 4-6 — vellus regrowth. Fine, light, downy hairs (vellus) appear in previously thinning zones. Easy to miss in a mirror. Visible in side-by-side photos under good lighting. Total density still feels low, but the trajectory has flipped.

Months 6-12 — terminal conversion. The vellus hairs thicken and pigment. By month 9-12 most responders see a clear visual difference vs month 0 photos. Frontal regions respond more slowly than the vertex; if your loss is mostly temples, this is when you'll know if you're a responder there at all.

Months 12-24 — the consolidation. Maximum gain on Big 3 alone is typically reached around month 18-24. After that, the protocol becomes a maintenance regimen — you're holding ground rather than recovering it. Keep all three legs going indefinitely. Stopping any one of them returns you to baseline within 12 months.

The full curve: get worse → no change → small wins → big wins → plateau. Quitting before month 6 is quitting before the curve turns. Most people quit before month 6.

Section 4 — The "optional 20%" decision tree

The Big 3 covers 80% of the hair you'll keep. The remaining 20% comes from tuning the protocol when something is off. Five branches:

Branch 1: Side effects on oral finasteride. First step is not to stop. It's to halve the dose. Drop to 0.5mg/day, or split a 1mg tab in half and take every other day (functionally ~0.5mg/day average). Hair-saving effect drops from 64% scalp DHT reduction to ~55-60%; side-effect rates drop disproportionately more. If the symptom persists after 4 weeks at 0.5mg, switch to topical finasteride 0.25%. Piraccini et al. JEADV 2022 (Phase III, doi:10.1111/jdv.17738) showed topical fin 0.25% spray achieved meaningful hair count gains (+20.2 hairs vs +6.7 placebo, P<.001) with serum DHT reduction of only 34.5% vs 55.6% for oral 1mg. See our topical finasteride deep dive.

Branch 2: Plateau on finasteride alone after 12 months. Add dutasteride 0.5mg/day (or switch from fin to dut). Dutasteride blocks both type 1 and type 2 5-alpha reductase; finasteride blocks mostly type 2. Serum DHT suppression goes from ~70% (fin) to ~95% (dut). The clinical hair benefit is real: Olsen EA et al. JAAD 2006;55(6):1014-1023 (n=416, 24-week head-to-head) showed dutasteride 2.5mg superior to finasteride 5mg at both 12 and 24 weeks across hair count, width, and investigator panel scoring. Side-effect rates track the stronger DHT suppression — sexual side effects in the dut arm ran a few percentage points higher than fin. Escalation move, not a starting move. See our dutasteride escalation guide.

Branch 3: Topical minoxidil is too messy / irritating. Switch to oral minoxidil 2.5mg/day. As above, the 2026 RCT showed comparable efficacy to 5mg with a cleaner side-effect profile, and the Vañó-Galván n=1,404 safety dataset is reassuring. Caveat: oral mino requires a prescription in the US and is off-label. The personal-import lane handles this; the US telehealth lane mostly doesn't.

Branch 4: Aggressive loss / Norwood VI+ / fast trajectory. Stack: oral finasteride 1mg + dutasteride 0.5mg (yes, both, in some protocols on alternating days or combined with caution) + oral minoxidil 2.5mg + topical minoxidil 5% + ketoconazole 2-3x/week + dermarolling 1.5mm weekly. This is a maximum-aggression regimen used for men who are losing fast and have decided to throw the kitchen sink at it. It is also the lane where side-effect risk goes up the steepest. Don't start here. Earn your way here over 12 months of the basic Big 3 first.

Branch 5: Onboarding shed is severe enough to consider quitting. This is the hardest branch because it is psychological. The shed is real. The feeling that "the drug is making it worse" is real. The data say it isn't, and that quitting at month 3 of the shed is the single most common reason men in their 30s end up bald in their 40s. Read the shedding onboarding piece before deciding.

Section 5 — What you can skip (the clinic-upsell traps)

Twelve things online clinics will sell you that don't move the needle, in roughly descending order of how often they're pitched.

1. Saw palmetto. A weak, plant-derived 5-alpha reductase inhibitor. Best estimate from independent reviews: ~2-5% effective compared to finasteride. Inconsistent trial data. If your hair is actively miniaturizing, saw palmetto buys you nothing measurable. Not a substitute for finasteride.

2. Biotin supplements. Only useful if you are biotin-deficient, which essentially never occurs in adults eating any normal diet. Won't hurt. Won't help. You're paying for urine.

3. "Scalp serum" with caffeine + redensyl + procapil + adenosine. No quality RCT data showing any of these molecules produce the results topical minoxidil does. Caffeine in particular has in vitro anti-androgenic data that has not translated to clinical hair-density gains in any well-controlled trial. $150 a bottle. Skip.

4. Hair growth gummies / collagen / "marine extract." Same category. The marketing photos are real users. The protocol they're actually on usually includes minoxidil that the brand doesn't disclose.

5. Laser caps / LLLT (low-level laser therapy). Marginal evidence. Some small RCTs show modest density gains. Cost $300-1,200 for the device. If you have $1,200 to spend on hair, it goes much further into 5 years of Big 3.

6. PRP (platelet-rich plasma) injections. $500-1,500 per session, 3-4 sessions per year. Some evidence of benefit as an adjunct, very little evidence of benefit instead of the Big 3. Don't do PRP until you've maxed out the Big 3 for 12 months.

7. Hair vitamins (Nutrafol, Viviscal). Brand-name multivitamin-plus-saw-palmetto blends marketed at hair retention. ~$80/month. The active ingredients with any evidence (saw palmetto, marine collagen) are weak; the rest is a multivitamin. Cheaper to take a $5 multivitamin and put the difference toward routed finasteride.

8. Caffeine shampoos. Same issue as caffeine serum. In vitro signal, no real clinical translation.

9. "Anti-DHT" shampoos that aren't ketoconazole. Most contain ketoconazole at sub-2% or use saw palmetto extract. If the active is ketoconazole 2%, fine — that's leg 3 of the Big 3. If it's "DHT-blocking proprietary blend," skip.

10. Scalp massagers / micro-needling devices under 1.0mm. Weak data. Dermarolling at 1.5mm has some evidence as a minoxidil potentiator. The vibrating scalp massager you saw on Instagram does not.

11. Diet changes targeted at hair. Unless you have an actual deficiency (iron in women, severe protein restriction in either sex), diet won't reverse androgenetic alopecia. The follicles aren't starving. They're being shrunk by a hormone.

12. Stress reduction protocols specifically for hair. Stress causes telogen effluvium, not pattern loss. Reducing stress is good for many things. It will not regrow a Norwood-3 hairline.

If you are tempted by anything in this list while you are still missing leg 3 of the Big 3 (ketoconazole), redirect that money. Same for anyone considering PRP before a full year on finasteride + minoxidil.

Section 6 — Price anchor across every tier

Real prices, verified mid-2026. Approximate per-month costs at the standard adult dose, no insurance, no first-fill promos.

Three clarifications on our column:

The Cipla 90-pack of Finpecia 1mg routed through us is $21.87 — that's $0.24/day, or about $7.30 per month. The smaller 30-pack runs $8.58 ($0.29/day, ~$8.60/mo). The cheapest direct equivalent we route is Curlzfin 1mg by Canixa at $4.20 for 30 tabs (~$4.20/mo), which is the same molecule. Either way, you are inside an order of magnitude of Roman's $16-20/mo and roughly 4-12x cheaper than Hims's $22/mo, Keeps's $25/mo, and brand Propecia's $86/mo.

For oral minoxidil, the routed catalog stocks two routes. Direct 2.5mg dosing: Minoxitop 2.5mg 30 tabs $22.94 (~$23/mo). Split 5mg → 2.5mg: Minoxitop 5mg 30 tabs $28.24 split in half lasts 60 days, so roughly $14/mo. Topical Tugain 5% 60ml at $20.54 covers about a month at 2mL/day, so roughly $20/mo (or less if you go light).

For ketoconazole specifically: OTC Nizoral 1% at any US drugstore is $15 and is sufficient for most people. This is the one leg of the Big 3 where we explicitly recommend the local US drugstore over routed delivery — time-to-product is faster, price is the same. Routed Ketoforce 2% cream from Healing Pharma is $9.41 per tube (or $17.88 for two, $24 for three) for people who specifically want 2% and don't have OTC access.

The molecule is the same whether it comes through us, CVS, or Hims. The decision isn't where you buy. It's whether you start, what dose, and what to add when.

Section 7 — If you're a woman

Female pattern hair loss (FPHL) shares the DHT mechanism with men, but the pharmacology stack is different in three load-bearing ways. If you're a woman and you read the protocol above and assumed "I just take what he takes" — stop. You don't.

Mechanism: DHT plus. FPHL is driven by the same 5-alpha-reductase / DHT / androgen-receptor axis, plus a few female-specific contributors: heightened androgen-receptor sensitivity in the central scalp, declining estrogen (peri- and postmenopause unmasks the latent androgenic signal), and hyperandrogenic states like PCOS that amplify the hormonal load.

Classification: Ludwig 1-3, not Norwood. Hair loss in women is diffuse central thinning with preservation of the frontal hairline, not the temple-vertex pattern men get. Ludwig 1 = mild thinning, the part widens. Ludwig 2 = moderate, central scalp visibly diffuse. Ludwig 3 = severe, central area approaches alopecia with the front-line still intact. Photograph the part-line straight down and compare year-over-year — that's the highest-signal angle.

Critical safety fact most articles miss: finasteride is teratogenic and contraindicated in women of childbearing age. This is not a hedge. Finasteride and dutasteride cause genital abnormalities in male fetuses (the FDA Pregnancy Category was historically X for finasteride). Pregnant women are not allowed to handle crushed or broken tablets because the drug absorbs through skin. If you are pregnant, trying to conceive, breastfeeding, or could become pregnant — oral 5-alpha-reductase inhibitors are off the table entirely. This is why the female stack swaps in different molecules.

The female-specific drug stack:

• Topical minoxidil 2-5% — same mechanism, same evidence base, fully appropriate. The 5% is FDA-approved for women and works better than 2%. Same Tugain bottle a man would use.
• Ketoconazole 2% shampoo 2-3x/week — works the same in women. Leg unchanged.
• Spironolactone 50-200mg/day — the female-stack workhorse. An aldosterone antagonist with anti-androgenic activity at the receptor. Sinclair RD (JEADV 2018) describes it as standard FPHL adjunct; routinely prescribed by GPs in the UK and Australia, off-label in the US. Side effects: BP drops, potassium can rise (avoid combining with K+-sparing diuretics or high-dose ACE inhibitors), menstrual irregularity in some users. Bloodwork at baseline and every 6 months. Not for use in pregnancy.
• Topical finasteride 0.25% — minimal systemic absorption, used in some FPHL protocols where androgen suppression is needed but oral 5-ARIs are contraindicated. Still requires the same precautions during conception/pregnancy. See topical fin spoke article.

What to skip if you're a woman: the same twelve clinic-upsell traps from Section 5, plus oral finasteride/dutasteride for anyone of childbearing age. The ad you'll see for "women's hair vitamins" is the same multivitamin-plus-saw-palmetto blend men get sold, with a different label and 30% markup.

The protocol below in Section 8 covers four starting points, not three. The fourth is yours.

Section 8 — Decision matrix: which protocol for which loss pattern

Three persona-shaped starting points. Not advice. A grid you can locate yourself on.

Norwood 2 / early temple recession / family history: The full Big 3 at standard doses. Finasteride 1mg/day + topical minoxidil 5% twice daily + ketoconazole 2% shampoo 2-3x/week. Total monthly cost routed: ~$30-40 all-in (Finpecia $7.30 + Tugain $20 + OTC Nizoral $15, or Ketoforce $9.41 instead). Reassess at month 12. If you're holding ground at year 1, you've won — keep going. If you're still losing, escalate to dut.

Norwood 3-4 / active vertex thinning / loss accelerating: Same Big 3 + add weekly dermarolling (1.5mm needle, 30 seconds per region, applied before topical mino on alternate days — the wound-healing response potentiates minoxidil absorption). Total cost: same Big 3 plus a $25 dermaroller (lasts ~6 months). At month 12, if response is partial, switch finasteride to dutasteride.

Side-effect concerned / family history of post-finasteride syndrome / very anxious about systemic suppression: Topical finasteride 0.25% solution (skip oral) + topical minoxidil 5% + ketoconazole 2%. The Piraccini 2022 data shows 34.5% serum DHT suppression with topical fin vs 55.6% with oral — meaningfully less systemic exposure, with hair benefit largely preserved. Trade-off: topical fin is harder to source consistently (most US telehealth doesn't carry it; it's a personal-import or compounded specialty), requires daily application discipline, and the 24-month efficacy data are slightly thinner than oral.

Aggressive loss / Norwood V-VI / Asian or Mediterranean ancestry with rapid recession: Big 3 + escalate to dutasteride at month 3 (not month 12) + add oral minoxidil 2.5mg from day 1 alongside topical. This is the maximum-aggression lane and it should be entered with eyes open about side-effect risk (especially the dut+oral mino combo). Photographs every month, not every quarter.

Female pattern loss / Ludwig 1-2 / diffuse central thinning: Topical minoxidil 5% twice daily + ketoconazole 2% shampoo 2-3x/week + oral spironolactone 50-200mg/day (start 50mg, titrate up over 8-12 weeks, monitor BP and potassium). No oral finasteride or dutasteride if you're of childbearing age. Photograph the part-line straight down monthly. Reassess at month 6 — spironolactone responds faster than fin does in men. If Ludwig has progressed to 3 or you've ruled out pregnancy entirely, topical finasteride 0.25% is the next add (still with the same handling precautions in any household with a woman of childbearing age).

For all five: if the protocol stack is not producing visible hold by month 12, the next step is a dermatologist, not more bottles. There is a small minority of androgen-receptor-hypersensitive cases where standard pharmacology can't keep up. They exist. Hair transplant is the conversation at that point. Most reading this aren't there.

Section 9 — Action in concrete 7-step form

If you've read to here and you're going to start, this week, do this in order:

1. Take baseline photos. Front, left, right, top-down vertex. Same lighting, dry hair. Save them with today's date. Buy a $5 ruler. This is your zero-point. Without it you cannot tell at month 12 whether you're winning.

2. Order the Big 3. A 90-pack of finasteride 1mg (Cipla Finpecia, $21.87 for ~3 months), a 60mL bottle of minoxidil 5% topical (Cipla Tugain, $20.54 ≈ 1 month) or 30 tabs oral minoxidil 5mg to split (Healing Minoxitop, $28.24 ≈ 60 days at 2.5mg), and OTC Nizoral 1% from the drugstore ($15) or routed Ketoforce 2% cream ($9.41/tube). Routed total: ~$45-55 for the first 1-2 months of supply. Lead time ~2 weeks.

3. Start finasteride immediately. 1mg/day, swallowed whole, with or without food. Same time daily.

4. Start minoxidil immediately. Topical 1mL twice daily, dry scalp, do not wash for 4 hours after. Or oral 2.5mg (split a 5mg tab) once daily.

5. Start ketoconazole 2-3x/week. Lather, 3-5 minutes on scalp, rinse. Use normal shampoo on the other days.

6. Take month-3 photos. It will look worse. This is the synchronized shed. Do not quit. Compare to month 0 anyway — that's the photo you'll thank yourself for at month 12.

7. Take month-6 and month-12 photos. The first real signal arrives between months 4 and 6. The clearest verdict comes at month 12. If at month 12 you have visible improvement, continue indefinitely. If you have stabilization without growth, continue indefinitely (you've stopped the bleed, which is itself a win). If you have continued visible loss, that's when escalation to dutasteride makes sense.

The protocol is boring. That is its strength. Hair drugs reward consistency over years. The men who win at this don't have better genes. They have a calendar and the discipline to take the same three things every day for two years.

A note on bias.

We route finasteride, dutasteride, minoxidil, and ketoconazole orders. Be aware of that.

LiberaCure routes orders to licensed personal-import pharmacies. Finpecia (by Cipla) and Tugain (by Cipla) are two of the products we ship most often. For dutasteride we route Veltride (by Intas Pharmaceuticals), Dutaheal (by Healing Pharma), and brand Avodart (by GSK) for the people who want it. For ketoconazole, our routed Ketoforce 2% sits next to OTC Nizoral 1% — and we'll tell you when the OTC option is the right one. So we have a financial reason to want this article to lead you toward "start the protocol."

The molecule is the same whether it comes from us, CVS, Hims, or Keeps. The decision isn't where you buy — it's whether you start, what dose, and what to add when.

For reference on our policy: LiberaCure reships once free if tracking shows lost in transit. Second reship also free. Crypto refund (BTC/ETH/USDT) on third failure. Crypto-only checkout — no credit card processor, which is part of the price gap to Hims/Keeps/Roman. If credit-card billing is a hard requirement, the US telehealth lane is what solves it. Roman runs $16-20/mo, Hims $22/mo, Keeps $25/mo for the same molecule that routes through us at $4-9/mo, but their cards work and we don't.

Read this with that in mind. The protocol above is what we'd tell a friend, not what maximizes reorder rate.

Sources:

• Kaufman KD et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol 1998;39(4 Pt 1):578-589. (PROPECIA pivotal, n=1,553.)
• Piraccini BM et al. Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial. J Eur Acad Dermatol Venereol 2022;36(2):286-294. doi:10.1111/jdv.17738
• Carvalho Fonseca LP, Miot HA, Prescendo Chaves CR, Müller Ramos P. Oral minoxidil 2.5 mg versus 5 mg for male androgenetic alopecia: a double-blind randomized clinical trial. J Am Acad Dermatol 2026 (PMID 40962189).
• Vañó-Galván S et al. Safety of low-dose oral minoxidil for hair loss: a multicenter study of 1,404 patients. J Am Acad Dermatol 2021;84(6):1644-1651. doi:10.1016/j.jaad.2021.02.054
• Piérard-Franchimont C et al. Ketoconazole shampoo: effect of long-term use in androgenic alopecia. Dermatology 1998;196(4):474-477. (PMID 9669136)
• Olsen EA et al. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride. J Am Acad Dermatol 2006;55(6):1014-1023. (n=416 head-to-head; dut 2.5mg superior to fin 5mg at 12 + 24 weeks.)
• Sinclair RD. Female pattern hair loss: current treatment concepts. J Eur Acad Dermatol Venereol 2018;32(5):666-677. (FPHL standard-of-care including spironolactone adjunct.)
• Famenini S, Slaught C, Duan L, Goh C. Demographics of women with female pattern hair loss and the effectiveness of spironolactone therapy. J Am Acad Dermatol 2015;73(4):705-706.
• Manabe M, Inui S, et al. Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version. J Dermatol 2018;45(9):1031-1043. (PMID 29863806)
• Hims, Keeps, Roman, CVS, Walmart, and SingleCare cash pricing data, May 2026.

— LiberaCure editorial. We route generic medication through licensed personal-import pharmacies. We don't dispense, prescribe, or warehouse. Read more about why.